Healthcare Realty Trust Incorporated

Healthcare Realty Trust Incorporated (HR) Market Cap

Healthcare Realty Trust Incorporated has a market capitalization of .

No quote data available.

CEO: Peter A. Scott

Sector: Real Estate

Industry: REIT - Healthcare Facilities

IPO Date: 1993-05-27

Website: https://www.healthcarerealty.com

Healthcare Realty Trust Incorporated (HR) - Company Information

Market Cap: -|Sector: Real Estate

Company Profile

Healthcare Realty Trust operates as a Real Estate Investment Trust (REIT), specializing in the acquisition, development, financing, and active management of income-generating real estate assets, predominantly serving outpatient healthcare providers throughout the United States. By September 30, 2020, its extensive portfolio comprised 211 properties located across 24 states, collectively spanning 15.5 million square feet and valued at approximately $5.5 billion. The company further provided comprehensive leasing and property management solutions for 11.9 million square feet nationwide.

Analyst Sentiment

63%
Buy

From 13 Active Polls

1Y Forecast: $22.33

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$21

Median

$22

High Bound

$24

Average

$22

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$22.33
▲ +6.28% Upside
Low Target
$21.00
-0% Risk
Median Target
$22.00
5% Mid
High Target
$24.00
14% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HEALTHCARE REALTY TRUST INC CLASS (HR) — Investment Overview

🧩 Business Model Overview

Healthcare Realty Trust Inc. operates as a specialized healthcare REIT focused primarily on medical office buildings (MOBs) and related healthcare real estate. The value chain centers on (1) owning and maintaining facilities that house outpatient physician practices, specialty clinics, and medical services, (2) leasing space under multi-year arrangements, and (3) managing the operating and capital requirements of buildings to preserve tenant quality and cash flow.

The core “stickiness” in this model is tenant-level and location-level: healthcare providers depend on physical access for patients, established patient flow, and operational continuity, while MOB landlords depend on long-duration leases, recurring rent streams, and capital programs that keep properties clinically and operationally suitable.

💰 Revenue Streams & Monetisation Model

Revenue is predominantly rent from leased medical office space, with monetisation tied to (1) occupancy and lease-up of available suites, (2) contractual rent escalations and market rent resets, and (3) additional income from property services or reimbursements where structures permit.

Margin drivers are largely structural and asset-specific:

  • Stability of cash rents: Longer lease durations and repeat demand for established locations support more predictable rental income.
  • Lease terms and rent escalators: Contract mechanics can provide inflation responsiveness, depending on the lease language.
  • Property-level expense management: Operating cost discipline and building systems efficiency influence net operating income.
  • Capital allocation quality: Renovations and modernization can protect demand and re-leasing outcomes, but require disciplined timing and cost controls.

🧠 Competitive Advantages & Market Positioning

The principal moat is high barriers to entry at the asset level combined with embedded tenant retention characteristics common to healthcare real estate.

  • Integrated ecosystem / patient-access moat: Healthcare providers benefit from established patient capture, referral patterns, and operational workflow that are difficult to replicate after relocating. This creates effective “switching costs” for tenants even if the economics are contractually lease-based.
  • Location scarcity in healthcare submarkets: MOB demand is tied to demographics, employment centers, and physician catchment areas. Building a comparable portfolio requires time, planning, and local entitlement processes.
  • Operational and capital know-how: Healthcare uses impose higher build-out and compliance needs (space configuration, HVAC requirements, life-safety specifications, and ongoing maintenance), favoring owners with execution capability and vendor relationships.

Competitive benchmarking: Healthcare REIT peers vary by asset type and end-market exposure. Two main comparators include:

  • Medical Properties Trust (MPW): More exposed to hospital-adjacent healthcare real estate and a different tenant/provider mix; HR’s specialization in MOBs typically emphasizes outpatient demand and patient-access characteristics rather than hospital leverage.
  • Welltower (WELL): Broad healthcare real estate focus (including senior living and post-acute components). HR differs by concentrating on MOBs, where rent durability is tied more directly to physician continuity and localized patient flow.
  • Ventas (VTR): More heavily weighted toward senior housing and related healthcare formats. HR’s MOB focus creates different drivers, including outpatient utilization and local specialty clinic growth.

Compared with these rivals, HR’s positioning is more tightly linked to outpatient care infrastructure and medical practice real estate, where tenancy and renewal economics depend on location-anchored access and facility suitability.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is driven by a combination of demographic demand and structural shifts in care delivery:

  • Shift from inpatient to outpatient care: Capacity growth increasingly occurs in physician offices, specialty clinics, and ambulatory settings—supporting sustained demand for MOB space.
  • Aging population and chronic disease prevalence: Higher utilization of outpatient services supports occupancy and leasing opportunities for healthcare space.
  • Expansion of specialty care and diagnostics: Specialty practices and outpatient procedures require dedicated, configurable space and ongoing facility modernization.
  • Healthcare delivery network consolidation: Mergers and multi-site practice models can increase “portfolio leasing” activity and improve lease commitment when systems standardize facility footprints.
  • Capital expenditure cycle and asset modernization: Building improvements can extend economic life, support higher-quality tenants, and reduce downtime during leasing transitions.

⚠ Risk Factors to Monitor

  • Interest rate and refinancing risk: As a REIT, financing conditions affect cost of capital, balance sheet flexibility, and the ability to fund development or renovation programs.
  • Tenant concentration and credit risk: MOB portfolios can experience pressure if tenant practices face reimbursement headwinds, consolidation, or cost squeezes.
  • Lease rollover and re-leasing execution risk: Occupancy stability depends on managing turnover, renovation timelines, and market rent resets.
  • Healthcare reimbursement and regulatory risk: Changes affecting utilization, site-of-care economics, or regulatory requirements can reduce demand for certain outpatient services or alter tenant affordability.
  • Capital intensity and building obsolescence: Healthcare facility requirements can evolve, increasing maintenance and upgrade needs. Poorly timed or under-scoped capex can impair re-leasing prospects.
  • Geographic and demographic variability: MOB demand is local; slower regional growth can affect leasing and renewal outcomes.

📊 Valuation & Market View

Healthcare REIT valuation typically reflects real estate cash flow characteristics rather than classic earnings multiples. Common market frameworks include:

  • EV/EBITDA and cap-rate assumptions: Property-level fundamentals, perceived risk of cash flows, and prevailing capitalization rates influence valuation.
  • AFFO-based metrics: Investors often anchor on cash earnings quality after recurring capital needs, since REITs distribute substantial portions of cash flow.
  • Balance sheet leverage and interest coverage: Debt maturity profile and the cost to refinance shape downside risk and equity risk premium.
  • Portfolio occupancy, rent growth visibility, and lease duration: Higher-quality lease profiles and stable tenant demand typically support a more favorable valuation.

The needle typically moves with changes in occupancy trends, renewal/re-leasing success, costs of capital, and the sustainability of cash flow given tenant credit conditions and capex requirements.

🔍 Investment Takeaway

Healthcare Realty Trust’s long-term investment case rests on owning MOB assets in markets where outpatient care demand is structurally supported, combined with an asset-level moat created by location scarcity, healthcare “switching costs”, and barriers tied to facility build-out requirements and operational execution. The principal determinants of value over a full cycle are rent stability, disciplined capital allocation, and balance sheet resilience through varying interest-rate environments.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"HR reported Q2 2026 revenue of $270.6M and net income of -$43.5M (EPS -$0.13). YoY (vs Q2 2025), revenue decreased -9.0% (from ~$297.5M) and net income deteriorated from -$157.9M to -$43.5M (an improvement of +72.4% in losses). QoQ (vs Q1 2026), revenue declined -3.0% (from ~$279.0M) while net income moved from roughly breakeven (-$56K) to -$43.5M, a sharp quarter-over-quarter decline. Profitability swung materially: gross margin improved to 62.9% in Q2 2026 from 64.1% in Q1 and was far higher than the negative gross margins seen through much of 2025. However, the quarter ended with a negative net margin (-16.1%), driven by a much weaker pre-tax/income-before-tax line. Cash-flow statements are not meaningfully usable in Q2 2026 (operating cash flow and free cash flow are reported as 0). Over the prior quarter, the company paid substantial dividends (~$83.9M) and repurchased shares (~$102.0M), but the net income volatility raises questions about near-term earnings-to-cash conversion. On shareholder returns, HR’s price performance was positive but not explosive: +18.15% over 1 year (below the >20% momentum threshold). The dividend yield is ~1.19%, supporting total-return durability despite earnings softness."

Revenue Growth

Caution

Revenue fell QoQ by -3.0% (278.99M to 270.55M) and declined YoY by -9.0% (297.50M to 270.55M), indicating a contracting top line.

Profitability

Caution

Net income worsened QoQ (about -$0.06M to -$43.5M). YoY losses improved materially (-$157.9M to -$43.5M, +72.4% improvement), but net margin remains negative (-16.1% in Q2 2026).

Cash Flow Quality

Neutral

Q2 2026 cash flow metrics are not interpretable (operating cash flow/free cash flow reported as 0). In Q1 2026, OCF was positive (~$52.9M) while dividends and buybacks were sizable, but earnings volatility complicates confidence.

Leverage & Balance Sheet

Neutral

Balance sheet appears more stable versus earlier quarters: total assets declined slightly to ~$9.00B from ~$9.15B, while equity remains sizable (~$4.27B). Debt remains present (total debt ~$236M) and net debt is much lower than prior periods.

Shareholder Returns

Fair

1-year price change is +18.15% (strong but below the >20% momentum threshold). Dividend yield is ~1.19%; however, current quarter earnings are negative, making coverage less certain.

Analyst Sentiment & Valuation

Fair

Consensus price target is ~$22 vs current ~$18.55 (upside implied), suggesting constructive sentiment; however, near-term profitability deterioration limits valuation confidence.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Healthcare Realty’s Q2 2026 call shows broad-based operating momentum: same-store cash NOI growth of 5.1% (almost the full portfolio), same-store occupancy near 93%, retention ~88.5% in Q2, and improving leasing economics. Management credited a new leasing model that lifted lease IRRs by nearly 3,000 bps and reduced payback by ~25%. Financial execution reinforced the story—normalized FFO per share of $0.41 and guidance raised to $1.64–$1.66, with same-store cash NOI guidance at 4.25%–5.00%. Capital allocation was proactive: $700M exchangeable notes at 3% (plus a delayed draw term loan) to manage maturities, ~100 bps interest savings versus prior guidance, and $75M repurchases in the quarter ($175M since the strategic plan). Strategic growth leans on health system deepening (CommonSpirit, Wellstar/Kennestone, Ascension St. Thomas) and scalable redevelopment with 10% underwriting yields. Key investor focus in Q&A centered on durability of the 3-year plan, KKR JV funding discipline, and redevelopment return/volume sustainability.

AI IconGrowth Catalysts

  • Same-store NOI growth averaging 5.7% over last 4 quarters; same-store occupancy rising to nearly 93% (retention ~90% average)
  • Improved leasing model: lease IRRs improved nearly 3,000 bps and payback period down nearly 25% over the last 4 quarters
  • Health system transaction execution driving leasing and visibility (WAL/WRL and renewal/new lease activity with multiple systems)
  • Signed not-occupied visibility: 460k sq ft representing ~140 bps of future occupancy

Business Development

  • CommonSpirit: ~160k sq ft renewals in 5 states; agreed to sell CommonSpirit 15 acres of Denver land for $16M; retained future MOB development rights under ground-lease structure
  • Wellstar: ~215k sq ft renewal leases + 27k sq ft new leases; agreed to sell Wellstar to Kennestone Cancer Center for $36M (~mid-5% cap rate); proceeds planned for JV acquisitions at higher yield
  • Ascension St. Thomas (Nashville): LOI for 203k sq ft across 3 campuses; expected Q3 execution; HR to invest $35M into 3 MOBs; Ascension leads $120M hospital modernization; extended Ascension leases 10 years with ~11% mark-to-market
  • KKR medical office JV partnership: closed/under contract/LOI ~ $200M total assets (~$40M at HR share); ~7.5% going-in cash yield vs implied ~6% cap rate; stated goal to grow medical office sector

AI IconFinancial Highlights

  • Normalized FFO per share (Q2): $0.41; same-store cash NOI growth 5.1% (almost entire portfolio)
  • FAD per share (Q2): $0.32; dividend payout ratio 76%
  • Q2 share repurchase: $75M; $175M repurchased since strategic plan start at blended ~$18.50 creating >$30M value for shareholders
  • Capital market actions: $700M exchangeable senior unsecured notes due 2032 at 3% coupon (upsized +$100M); repaid $600M 3.5% senior unsecured notes due August
  • Blended interest rate on new capital ~4%; saving ~100 bps vs original guidance
  • Leverage down nearly a full turn (management stated); keeping leverage in mid-5x area
  • Redevelopment: invested ~$25M in quarter; leased up to 67% (improvement of +1.4 thousand bps over last 4 quarters); underwriting 10% cash-on-cash yields
  • Guidance update: full-year normalized FFO per share increased by $0.02 to $1.64 at midpoint; upper end to $1.66
  • Same-store cash NOI outlook: 4.25% to 5.00% (up +50 bps at bottom and +25 bps at upper end); driven by 4% to 5% cash releasing spreads YTD
  • Signed not occupied leases: 460k sq ft (~140 bps of future occupancy); quarter ended with ~3M sq ft pipeline

AI IconCapital Funding

  • Convertible/exchangeable issuance: $700M exchangeable senior unsecured notes due 2032 at 3% coupon (upsized by $100M during marketing)
  • Debt maturity management: repaid $600M senior unsecured notes due August; raised $400M delayed draw term loan
  • Liquidity: $1.2B additional liquidity on line of credit; management indicated ample flexibility through 2029
  • Share repurchase capacity referenced: can repurchase $75M of shares with the offering; Q2 repurchases totaled $75M
  • Capital recycling/dispositions: YTD disposed 6 buildings and 3 land parcels for ~$75M at ~5% cap rate; additional disposition pipeline nearly $200M
  • Uses of capital guidance: increased $115M for the year (incremental share repurchases alongside exchangeable notes + $40M to fund JV share of acquisitions)

AI IconStrategy & Ops

  • Redevelopment execution: 67% leased; absorption and occupancy gains tied to redevelopment leasing progress
  • New leasing model: improved ROI across portfolio; lease IRRs +~3,000 bps; payback down ~25%
  • Tenant retention/experience improvements: third-party tenant survey showed YoY improvement across every metric
  • Operational focus: tenant satisfaction and reduced leasing capital intensity (renewals require a fraction of capital vs new leases)
  • Back-half visibility enhancement: 460k sq ft signed not occupied implies additional occupancy gains

AI IconMarket Outlook

  • Back-half of year expectations: strong leasing momentum, high tenant retention, and improving lease economics driving same-store NOI growth
  • Full-year same-store cash NOI guidance: 4.25% to 5.00%
  • Full-year normalized FFO per share guidance: $1.64 midpoint; range adjusted to $1.64-$1.66

AI IconRisks & Headwinds

  • No explicit macro/tariff/yield bps risk quantified in transcript; management emphasized “limited near-term exploration risk” and reiterated disciplined capital allocation
  • Potential private-market pricing/cap-rate pressure acknowledged but stated as “not a big impact right now” given monitoring; early days

Q&A: Analyst Interest

  • 2028/strategic-plan earnings outlook: Management (Peter Scott) said the company is tracking ahead of the 12-quarter plan, attributing progress to the convert transaction and better-than-expected same-store NOI. He clarified guidance is AFFO (not FFO) and avoided exact 2028 numbers, citing $0.03 growth mid-year versus last year and only half-year convert benefit.
  • KKR medical office JV sizing, funding, and NAV discipline: Management explained KKR JV growth required HR’s “optimization” to unlock vehicle free cash flow. He cited roughly $300M total deals in 2026 (closed/under contract), matched by HR share sizing. Funding is primarily capital recycling and free cash flow; if equity is more accretive than dispositions, they may pivot, but today they have stayed disciplined.
  • Redevelopment shadow pipeline and returns range drivers: Management expected redevelopment absorption to continue given preleasing improvement of +1.4 thousand bps. He described ~25 assets in redevelopment today, with non-included Ascension St. Thomas campus assets likely pushing to ~30 before cycling completed assets out. For returns, he said current pipeline sits near mid-range; Nashville is closer to ~9% vs ~12% when more rate uplift drives outcomes.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the HR Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Healthcare Realty Trust Incorporated (HR) Financial Profile